XML 79 R20.htm IDEA: XBRL DOCUMENT v3.25.2
Income Taxes
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Income Taxes

Note 13 – Income Taxes

 

The Company’s quarterly tax provision and estimate of its annual effective tax rate is subject to variation due to several factors, including variability in pre-tax income (or loss), the mix of jurisdictions to which such income (or loss) relates, changes in how the Company does business, and tax law developments. The Company’s estimated effective tax rate for the year differs from the U.S. statutory rate of 21% primarily as a result of not benefiting U.S. losses as those losses are not more likely than not to be realized, as well as its foreign operations, which are subject to tax rates that differ from those in the United States.

 

The Company recorded an income tax expense of nil and approximately $50 for the six months ended June 30, 2025 and 2024, respectively.

 

Note 13 – Income Taxes Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

 

TG-17 INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Net deferred tax items consist of the following components as of December 31, 2024 and 2023 (in thousands):

 

           
   December 31, 
   2024   2023 
Deferred tax assets:          
Net operating loss carryover  $17,736   $15,976 
Net operating loss carryover - States   4,471    4,283 
R&D credit carryforward   325    325 
Stock-based compensation   390    200 
R&D capitalization   2,210    1,790 
Other   6     
Deferred tax liabilities          
Depreciation   (48)   (36)
Other       (13)
Valuation allowance   (25,090)   (22,525)
Net deferred tax asset  $   $ 

 

The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income for the year ended December 31, 2024 due to the following (in thousands):

 

           
   December 31, 
   2024   2023 
Book income (loss)  $(2,320)  $(2,575)
Non deductible other expenses (M&E 50% and penalties)   1    1 
State income taxes, net of federal tax benefit
   (246)    
Valuation allowance   2,565    2,574 
 Total Income Tax Provision  $   $ 

 

At December 31, 2024, the Company had net operating loss carryforwards of approximately $84 million that may be offset against future taxable income varying from the year 2024 through indefinitely. No tax benefit has been reported in the December 31, 2024, financial statements since the potential tax benefit is offset by a valuation allowance of the same amount.

 

Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carryforwards for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carryforwards may be limited as to use in future years. NOLs arising in tax years beginning in 2018 may be carried forward indefinitely.